Aktuelle Veröffentlichungen der Abteilung
- Singer, S., Hammerlid, E., Tomaszewska, I.M. et al.: Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale, in: Quality of Life Research (2021), published: 16. Juli 2021 (abgerufen am 20.07.2021)
- Prof Joël Guigay, MD, Anne Aupérin, MD, Jérôme Fayette, MD, Esma Saada-Bouzid, MD, Cédrik Lafond, MD, Miren Taberna, MD et al.: Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial, in: The Lancet Oncological, VOLUME 22, ISSUE 4, P463-475, APRIL 01, 2021 (abgerufen am 20.07.2021).
